RS
RVMD icon

Rakuten Securities’s Revolution Medicines RVMD Stock Holding History

Rakuten Securities’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.5K Buy
+350
New +$51.1K 0.02% 250
2025
Q4 		– Sell
-200
Closed -$9.34K – 964
2025
Q3 		$9.34K Hold
200
– – ﹤0.01% 417
2025
Q2 		$7.36K Hold
200
– – ﹤0.01% 452
2025
Q1 		$7.07K Buy
+200
New +$8.12K ﹤0.01% 447

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Rakuten Securities's RVMD Position: Q2 2026 in Review

Rakuten Securities opened a new position in Revolution Medicines (RVMD) in Q2 2026: 350 shares worth $65.5K. The stake represents 0.02% of the portfolio and ranks #250 among its holdings. This is a return to the name: Rakuten Securities previously reported a position in RVMD as recently as Q3 2025.

Rakuten Securities first reported a position in RVMD in Q1 2025 and has held it in 4 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Rakuten Securities held 350 shares of Revolution Medicines worth $65.5K as of Q2 2026.
  • Revolution Medicines was a new Rakuten Securities position in Q2 2026.
  • Revolution Medicines made up 0.02% of Rakuten Securities's portfolio in Q2 2026, its #250 holding.
  • Rakuten Securities first reported a position in Revolution Medicines in Q1 2025 and has held it in 4 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.